JOHNSON JOHN sold 11.4% of their position (107.50K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $786.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/15/2025ACC: 0001867096-25-000141
Director
Since Oct 2021
-107.50K
Net shares
Net seller
$786.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
107.50K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−107.50K
Price / share
$7.32
Trade value
$786.46K
% of position
11.4%
8/13/2025
940.98K→833.48K
Total
Net shares
−107.50K
Net value
-$786.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2025 | S · Sale | −107.50K | $7.32 | $786.46K | 11.4% | 940.98K | 833.48K |
| Total | −107.50K | -$786.46K | ||||||
Derivative Transactions0
No derivative transactions reported